Your browser doesn't support javascript.
loading
Adjunctive Volasertib in Patients With Acute Myeloid Leukemia not Eligible for Standard Induction Therapy: A Randomized, Phase 3 Trial.
Döhner, Hartmut; Symeonidis, Argiris; Deeren, Dries; Demeter, Judit; Sanz, Miguel A; Anagnostopoulos, Achilles; Esteve, Jordi; Fiedler, Walter; Porkka, Kimmo; Kim, Hee-Je; Lee, Je-Hwan; Usuki, Kensuke; D'Ardia, Stefano; Won Jung, Chul; Salamero, Olga; Horst, Heinz-August; Recher, Christian; Rousselot, Philippe; Sandhu, Irwindeep; Theunissen, Koen; Thol, Felicitas; Döhner, Konstanze; Teleanu, Veronica; DeAngelo, Daniel J; Naoe, Tomoki; Sekeres, Mikkael A; Belsack, Valerie; Ge, Miaomiao; Taube, Tillmann; Ottmann, Oliver G.
Afiliación
  • Döhner H; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany.
  • Symeonidis A; Hematology Division, University Hospital, University of Patras Medical School, Patras, Greece.
  • Deeren D; AZ Delta, Roeselare, Belgium.
  • Demeter J; Semmelweis University, Budapest, Hungary.
  • Sanz MA; Department of Hematology, University Hospital La Fe, Valencia, Spain.
  • Anagnostopoulos A; Hematology Department, General Hospital G. Papanikolaou, Thessaloniki, Greece.
  • Esteve J; Hospital Clinic de Barcelona, IDIBAPS, Barcelona, Spain.
  • Fiedler W; Department of Medicine II, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany.
  • Porkka K; Department of Hematology, Helsinki University Hospital Cancer Center, Helsinki, Finland.
  • Kim HJ; Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Lee JH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Usuki K; NTT Medical Center Tokyo, Japan.
  • D'Ardia S; A.O. Città della Salute e della Scienza, Torino, Italy.
  • Won Jung C; Samsung Medical Center, Seoul, South Korea.
  • Salamero O; Hospital Vall d'Hebron/VHIO/UAB-Medicine, Barcelona, Spain.
  • Horst HA; UKSH Campus Kiel, Kiel, Germany.
  • Recher C; Centre Hospitalier Universitaire de Toulouse, IUCT-Oncopole, Université Paul Sabatier Toulouse 3, Toulouse, France.
  • Rousselot P; Centre Hospitalier de Versailles, University Versailles Saint-Quentin and Paris Saclay, Le Chesnay, France.
  • Sandhu I; Division of Hematology, Department of Medicine, University of Alberta, Edmonton, AB, Canada.
  • Theunissen K; Jessa Ziekenhuis, Hasselt, Belgium.
  • Thol F; Medizinische Hochschule Hannover, Germany.
  • Döhner K; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany.
  • Teleanu V; Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany.
  • DeAngelo DJ; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Naoe T; National Hospital Organization Nagoya Medical Center, Nagoya, Japan.
  • Sekeres MA; Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.
  • Belsack V; SCS Boehringer Ingelheim Comm.V, Brussels, Belgium.
  • Ge M; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USA.
  • Taube T; Boehringer Ingelheim International GmbH, Biberach, Germany.
  • Ottmann OG; Goethe University, Frankfurt/Main, Germany.
Hemasphere ; 5(8): e617, 2021 Aug.
Article en En | MEDLINE | ID: mdl-34350385
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Hemasphere Año: 2021 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Hemasphere Año: 2021 Tipo del documento: Article País de afiliación: Alemania